Live vaccines for infants exposed to biological immunosuppressive therapies in utero, except anti-CD20 therapies, such as rituximab
Live vaccines for infants exposed to anti-CD20 therapies, such as rituximab, in utero
<6 months
Give all non-live vaccines according to the routine schedule. Give a single dose of RSV-specific monoclonal antibody regardless of maternal vaccination status
Give rotavirus vaccine according to the routine schedule. Do not give BCG vaccine or other live vaccines.
Do not give rotavirus vaccine to infants exposed to anti-CD20 therapies in utero at any gestational age.
Do not give any other live vaccines to infants aged <6 months who were exposed to anti-CD20 therapies in utero.
≥6 months
Give all non-live vaccines according to the routine schedule. Give an additional dose of PCV at age 6 months.
Give live vaccines as scheduled, including BCG vaccine or measles-containing vaccine, if indicated for certain circumstances (e.g. before overseas travel).
Give live vaccines as scheduled, including BCG vaccine if indicated. Do not give rotavirus vaccine, as the infant will be above the recommended age of administration.
